Skip to main content

Table 1 Clinicopathological characteristics of gastric cancer patients

From: Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients

Characteristics

No. of patients (%)

Gender

 

Male

84 (81.5)

Female

19 (18.5)

Age, years

 

Mean

58.8

SD

12.9

Tumor localization

 

gastric cardia

20 (19.4)

gastric body

32 (31.1)

gastric antrum

51 (49.5)

Tumor size (cm3)

 

≤3

32 (31.1)

3-5

36 (35.0)

>5

35 (33.9)

Differentiation

 

well/moderate

48 (46.6)

poor/undifferentiation

55 (53.4)

Tumor invasion

 

T1

23 (22.3)

T2

14 (13.6)

T3

52 (50.5)

T4

14 (13.6)

TNM stage

 

I

9 (8.7)

II

41 (39.8)

III

47 (45.6)

IV

6 (5.8)

Lymph node metastasis (LNM)

 

Yes

48 (46.6)

No

55 (53.4)

No. of LNM

 

N0

55 (53.4)

N1 (1–6)

34 (33.0)

N2 (7–15)

10 (9.7)

N3 (≥16)

4 (3.9)

Survival status

 

Dead

45 (43.7)

Alive

58 (56.3)